Navigation Links
aRNA in Medical News

Arena Pharmaceuticals Announces Second Quarter 2009 Financial Results and Recent Developments

... SAN DIEGO, Aug. 3, 2009 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc. (Nasdaq: arna ) today reported financial results for the second quarter ended June 30, 2009. Arena reported a lower net loss allocable to common stockholder...

Arena Pharmaceuticals to Present at the BMO Capital Markets 9th Annual Focus on Healthcare Conference

... SAN DIEGO, July 30, 2009 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc. (Nasdaq: arna ) announced today that the company is scheduled to present at the BMO Capital Markets 9th Annual Focus on Healthcare Conference on August 5, 2009 at...

Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Monday, August 3, 2009

... SAN DIEGO, July 29, 2009 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc. (Nasdaq: arna ) today announced it will report second quarter 2009 financial results after the NASDAQ Global Market closes on Monday, August 3, 2009. That same afte...

Arena Pharmaceuticals Announces Pricing of Public Offering of Common Stock

... SAN DIEGO, July 8, 2009 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc. (Nasdaq: arna ) announced today the pricing of its public offering of 12,500,000 shares of its common stock at a public offering price of $4.17 per share. All of th...

Arena Pharmaceuticals Announces Public Offering of Common Stock

... SAN DIEGO, July 7, 2009 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc. (Nasdaq: arna ) announced today that it intends to offer shares of its common stock in a public offering. Piper Jaffray & Co. will be the sole underwriter for t...

American Orthopaedic Society for Sports Medicine (AOSSM) Presents Prestigious Research Awards at Annual Meeting

...rican Journal of Sports Medicine will be presented to Britt Elin Øiestad, PT, MS, Lars Engebretsen, MD, PhD, Kjersti Storheim, PT, PhD, and May arna Risberg, PT, PhD for their paper "Knee osteoarthritis after anterior cruciate ligament injury - A systematic review." In this paper, the aut...

Arena Pharmaceuticals to Present at the Piper Jaffray Fourth Annual Europe Conference

... SAN DIEGO, June 18, 2009 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc. (Nasdaq: arna ) announced today that the company is scheduled to present at the Piper Jaffray Fourth Annual Europe Conference on June 23, 2009 at 9:30 a.m. Britis...

Arena Pharmaceuticals to Receive $100 Million from Deerfield Management

... SAN DIEGO, June 17, 2009 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc. (Nasdaq: arna ) announced today that it has entered into an agreement with Deerfield Management, a leading healthcare investment organization and significant Aren...

Arena Pharmaceuticals to Present at the 34th Annual Deutsche Bank Health Care Conference

... SAN DIEGO, May 13, 2009 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc. (Nasdaq: arna ) announced today that the company is scheduled to present at the 34th Annual Deutsche Bank Health Care Conference on May 19, 2009 at 10:10 a.m. Eas...

Arena Pharmaceuticals Announces Positive Lorcaserin Pivotal Phase 3 Obesity Trial Results: Meets All Primary Efficacy and Safety Endpoints

... Conference Call Scheduled for Today at 8:30 a.m. EDT SAN DIEGO, March 30, 2009 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc. (Nasdaq: arna ) announced today positive top-line results from BLOOM (Behavioral modification and Lorcaserin for Overweight and Obesity Management), the first of tw...

Arena Pharmaceuticals to Report Fourth Quarter and Full Year 2008 Financial Results and to Host Conference Call and Webcast on Thursday, March 12, 2009

... SAN DIEGO, March 5 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc. (Nasdaq: arna ) today announced it will report fourth quarter and full year 2008 financial results after the NASDAQ Global Market closes on Thursday, March 12, 2009...

Arena Pharmaceuticals Announces Initiation by Merck of Phase 2 Clinical Trial of Niacin Receptor Agonist

... SAN DIEGO, Feb. 18 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc. (Nasdaq: arna ) announced today the initiation of a Phase 2 clinical trial of an orally administered niacin receptor agonist drug candidate being developed by Mer...

Arena Pharmaceuticals to Present at the BIO CEO & Investor Conference

... SAN DIEGO, Feb. 4 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc. (Nasdaq: arna ) announced today that the company is scheduled to present at the BIO CEO & Investor Conference on February 10, 2009 at 1:45 p.m. Eastern Time (...

Arena Pharmaceuticals to Host Research & Development Day on December 15, 2008

... SAN DIEGO, Dec. 8 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc. (Nasdaq: arna ) announced today that it will host a Research and Development Day on Monday, December 15, 2008, beginning at approximately 12:00 p.m. Eastern Time (9...

Arena Pharmaceuticals Announces Lorcaserin Phase 2b Clinical Trial Results Published in Obesity

... SAN DIEGO, Dec. 8 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc. (Nasdaq: arna ) announced today publication of the Phase 2b clinical trial results of lorcaserin, its novel drug candidate for the treatment of obesity, in the Dece...

Arena Pharmaceuticals to Present at the Piper Jaffray 20th Annual Health Care Conference

... SAN DIEGO, Nov. 25 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc. (Nasdaq: arna ) announced today that the company is scheduled to present at the Piper Jaffray 20th Annual Health Care Conference on December 3, 2008 at 2:30 p.m. Ea...

Arena Pharmaceuticals Announces Third Quarter 2008 Financial Results

... SAN DIEGO, Oct. 30 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc. (Nasdaq: arna ) today reported financial results for the third quarter ended September 30, 2008. Arena reported a net loss allocable to common stockholders in the...

Study finds that significant proportion of men told wife's cancer was incurable late or not at all

...ease, and if so, when and by whom. They were also asked about their desire to learn such information. The study is part of a larger data collection by arna Hauksdottir and colleagues, who are investigating men's preparedness for the death of a spouse. Twenty percent of the men reported they were never ...

Arena Pharmaceuticals to Report First Quarter 2008 Financial Results and to Host Conference Call and Webcast on Wednesday, May 7, 2008

... SAN DIEGO, April 30 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc. (Nasdaq: arna ) today announced it will report first quarter 2008 financial results after the NASDAQ Global Market closes on Wednesday, May 7, 2008. That same after...

Arena Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Unplugged Conference

... SAN DIEGO, April 28 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc. (Nasdaq: arna ) announced today that the company is scheduled to present at the Morgan Stanley Global Healthcare Unplugged Conference on May 2, 2008 at 9:50 a.m. Ea...

Arena Pharmaceuticals' Lorcaserin for Obesity Passes Major Safety Milestone

...trengthens Lorcaserin's Emerging Cardiovascular Safety Profile - SAN DIEGO, March 17 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc. (Nasdaq: arna ) announced today that following a planned review by an independent Echocardiographic Data Safety Monitoring Board (EDSMB) it is continuing BLOOM (Beh...

Arena Pharmaceuticals to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference

... SAN DIEGO, Jan. 30 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc. (Nasdaq: arna ) announced today that the company is scheduled to present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference on ...

Arena Pharmaceuticals Announces Pricing of Public Offering of Common Stock

... SAN DIEGO, Nov. 1 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc. (Nasdaq: arna ) announced today the pricing of its public offering of 11,000,000 shares of its common stock at a public offering price of $9.91 per share. All of th...

Arena Pharmaceuticals to Present at the BIOCOM Investor Conference

... SAN DIEGO, Oct. 29 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc. (Nasdaq: arna ) announced today that the company is scheduled to present at the BIOCOM Investor Conference on November 2, 2007 at 1:00 p.m. Pacific Time (4:00 p.m. ...

Arena Pharmaceuticals Announces Public Offering of Common Stock

... SAN DIEGO, Oct. 19 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc. (Nasdaq: arna ) announced today that it has filed a preliminary prospectus supplement to a shelf registration statement with the Securities and Exchange Commission ...

HealthShares(TM) Announces Quarterly Rebalancing of HealthShares(TM) Indexes

...harmaceuticals WPI 106757472.3 Nastech Pharmaceutical Co NSTK 242705714.4 Arena Pharmaceuticals Inc arna 247452278.7 Solvay SA SOLB BB 18643313.69 Ligand Pharmaceutical Inc LGND 421153847.7 Huma...

Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference

... SAN DIEGO, Aug. 31 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc. (Nasdaq: arna ) announced today that the company is scheduled to present at the NewsMakers in the Biotech Industry Conference on September 6, 2007 at 10:00 a.m. Eas...
Other Tags
(Date:7/9/2014)... derived from the oils produced by algae may offer ... this goal, optimization of cost effective strategies for large-scale ... needed. Sapphire Energy has developed an innovative solution to ... systems, described in Industrial Biotechnology , a peer-reviewed ... is available on the Industrial Biotechnology ...
(Date:7/9/2014)... about the prevalence of antibiotic-resistant illness, Case Western ... to disabling disease: blocking bacteria,s access to iron ... bacterial siderophore, a small molecule, captures iron from ... as well as how the body launches ... findings appear in a recent edition of ...
(Date:7/9/2014)... usually announce themselves with pain and fever but often can ... that are sneaky and hard to beat. Now, scientists have ... of tiny DNA pyramids. Published in the journal ACS ... can flag bacteria and kill more of them than medicine ... some infectious pathogens can lie in wait, undetectable in the ...
Breaking Biology News(10 mins):Controlling contamination in open algae ponds for biofuels 2Bacteria hijack plentiful iron supply source to flourish 2
(Date:7/9/2014)... that sudden, acute episodes of low back pain are ... air pressure, wind direction and precipitation. Findings published in ... the American College of Rheumatology (ACR), indicate that the ... wind speed or wind gusts, but was not clinically ... (WHO) nearly everyone experiences low back pain at some ...
(Date:7/9/2014)... Susan Wakulich was told she had an aneurysm, she figured ... her. , "I was devastated," said Wakulich, who is 56 ... this was a serious diagnosis. Then I met Dr. Bernard ... a less invasive procedure. It was something I didn,t even ... a multi-center U.S. clinical trial to evaluate the safety and ...
(Date:7/9/2014)... into the metabolism of stromal support cells and immune ... these cell types in the development of diseases ... and cancer. That was the conclusion of a review ... the leading journal Nature . , Prof. Peter ... call. The metabolism of cancer cells has been examined ...
(Date:7/9/2014)... from The Miriam Hospital have found that people ... also depressed have difficulty sticking to a pulmonary ... for women, and screening and brief treatment of ... The study and its findings are published in ... Chronic obstructive pulmonary disease is a common and ...
(Date:7/9/2014)... Montefiore Medical Center and the Albert ... present new findings at the Alzheimer,s Association International Conference ... Copenhagen, Denmark. Data from the four abstracts will focus ... to mild cognitive impairment and dementia. The research is ... in 1980 to examine healthy brain aging as well ...
Breaking Medicine News(10 mins):Health News:Low back pain? Don't blame the weather 2Health News:New type of stent could help some brain aneurysm patients 2Health News:Wake-up call for more research into cell metabolism 2Health News:Miriam Hospital study examines effect of depressed mood on pulmonary rehab completion 2Health News:Investigators from Montefiore and Einstein to present data at 2014 Alzheimer's Association International Conference 2Health News:Investigators from Montefiore and Einstein to present data at 2014 Alzheimer's Association International Conference 3
Other Contents